Clinical Trial Update: Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on combining an anti-PD-1 antibody with chemotherapy for unresectable intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: Zhejiang University | Conditions: Intrahepatic Cholangiocarcinoma by AJCC V8 Stage | Phase 2 | Status: UNKNOWN